Login

News Post

Indian Space Station will enable research in Bioastronautics, biological research, drug discovery: Isro Chairman

Economic TimesEconomic Times · 16d
Indian Space Station will enable research in Bioastronautics, biological research, drug discovery: Isro Chairman

India's space agency, the Indian Space Research Organisation (ISRO), plans to establish a space station that will enable astronauts to conduct various research activities. The station will focus on areas such as bioastronautics, biological research, drug discovery, and material science research. ISRO is also exploring collaboration opportunities with other nations to build and utilize space stations, as well as joint missions. The space agency has approved four projects, including the Chandrayaan-4 mission, a Venus Orbiter mission, a new generation launch vehicle, and the Bharatiya Antariksh Station, with a budget of around Rs. 22,000 crore. The long-term vision includes landing on the moon by 2040 and operating a space station by 2035.

View Source

Comments

More Like this

Transcell Biologics secures funding from IAN & Quantiphi

Transcell Biologics secures funding from IAN & Quantiphi

Multiples PE-backed Quantiphi, IAN bet on Transcell Biologics

Multiples PE-backed Quantiphi, IAN bet on Transcell Biologics

With refinancing done, focus will now be on debt reduction: Biocon Biologics CFO

With refinancing done, focus will now be on debt reduction: Biocon Biologics CFO

Deeptech startup Algorithmic Biologics secures pre-Series A funding of $2.5M

Deeptech startup Algorithmic Biologics secures pre-Series A funding of $2.5M

ChrysCap-backed Eris Life acquires Biocon Biologics' India formulations business

ChrysCap-backed Eris Life acquires Biocon Biologics' India formulations business

Biocon Biologics to sell branded formulations biz to Eris Life for ₹1,242 cr

Biocon Biologics to sell branded formulations biz to Eris Life for ₹1,242 cr

AI may enable large-scale biological attacks: Anthropic CEO

AI may enable large-scale biological attacks: Anthropic CEO

Eris Lifesciences acquires India-branded formulation business of Biocon Biologics for ₹1,242 crore

Eris Lifesciences acquires India-branded formulation business of Biocon Biologics for ₹1,242 crore

Bioptimus Raises $35M in Seed Funding

Bioptimus Raises $35M in Seed Funding

Private equity firm True North sees another top executive movement

Private equity firm True North sees another top executive movement

Download the medial app to read full posts, comements and news.